Budget 2014

Presenting Sponsor : JK TyrePowered By : LG OLED TV
You are here:HomeBudgetPharma

Pharma

  • Industry Body Seeks Prime Minister's Intervention Over Drug Price Fixing

    Industry Body Seeks Prime Minister's Intervention Over Drug Price Fixing

    Industry chamber CII has sought Prime Minister Narendra Modi's intervention over "unilateral fixing" of drug prices by the National Pharmaceutical Pricing Authority (NPPA) saying the exercise based on "an inequitable formula" has done collateral damage to the ndigenous industry.

  • Ipca Halts Shipments to US From Ratlam Plant After FDA Concerns

    Ipca Halts Shipments to US From Ratlam Plant After FDA Concerns

    Ipca, a mid-sized generic drugs and ingredients maker, said the FDA issued a so-called "Form 483", a letter in which the agency typically outlines violations of its guidelines observed during inspections of manufacturing plants. Ipca did not give details about the contents of the Form 483 that it had received.

  • Price Performance of Pharma Stocks Other Stories
  • IPCA Lab Falls 8% on Suspension of US Shipments

    IPCA Lab Falls 8% on Suspension of US Shipments

    The voluntarily stoppage of API shipments will impact IPCA Lab's formulations export business to the US market since its formulations units situated at Piparia (Silvassa) and SEZ, Indore (Pithampur) use APls from Ratlam for manufacturing formulations for the US market.

  • GSK CEO Says Significant Interest in Auction of Mature Drugs

    GSK CEO Says Significant Interest in Auction of Mature Drugs

    Andrew Witty said he hoped to sell the portfolio of mature drugs, known as established products, by the end of the year.

  • Strides Arcolab Gets US Regulatory Nod to Sell Transplant Drug

    Strides Arcolab Gets US Regulatory Nod to Sell Transplant Drug

    As per a global consumer confidence index study by Nielsen, India which was ranked second in the first quarter of 2013 is now the most optimistic country, followed by Indonesia and the Philippines.

  • Indoco Remedies Gets Approval From US Drug Regulator for Goa Facilities

    Indoco Remedies Gets Approval From US Drug Regulator for Goa Facilities

    Pharma player Indoco Remedies on Monday said it has received a nod from the US Food and Drug Administration (FDA) for two of its facilities in Goa.

  • Strides to Take Control of Bafna's India Branded Generics Buisness

    Strides to Take Control of Bafna's India Branded Generics Buisness

    Drug firm Strides Arcolab will acquire a majority stake in the India-branded generics business of Bafna Pharmaceuticals for a cash consideration of Rs 48.1 crore.

  • Sun Pharma-Ranbaxy Deal Gets BSE, NSE Clearance

    Sun Pharma-Ranbaxy Deal Gets BSE, NSE Clearance

    The 'no-objection' from the two exchanges would allow the two companies to file with the High Court for further clearance of the deal and marks one of the numerous regulatory approvals that Sun they need to consummate the transaction.

  • Price Cap: Drug Makers' Profitability May Come Under Pressure, Says Icra

    Price Cap: Drug Makers' Profitability May Come Under Pressure, Says Icra

    With the drug price control order (DPCO) coverage extending to almost 40 per cent of the industry, profitability in the domestic business of pharma companies is likely to come under pressure, according to rating agency Icra.

  • Why Premium Condoms Risk Extinction in India

    Why Premium Condoms Risk Extinction in India

    The Chennai-based TTK Protective Devices, which manufactures the 'Skore' brand of condoms, has moved the Madras High Court with a plea to take condoms off the essential medicine list.

  • FedEx Faces US Charges Over Online Pharmacies

    FedEx Faces US Charges Over Online Pharmacies

    FedEx Corp was indicted on Thursday for shipping packages from illegal online pharmacies despite repeated warnings from US drug enforcement officials, according to a court filing.

  • Glenmark to Set up First Manufacturing Facility in US

    Glenmark to Set up First Manufacturing Facility in US

    The proposed facility at Monroe, North Carolina, will cater only to the US market and is the company's first manufacturing facility in North America adding to its list of 14 plants in four countries - India, Brazil, Argentina and Czech Republic.

  • Infosys Co-founder Donates $1.8 million for Brain Research

    Infosys Co-founder Donates $1.8 million for Brain Research

    "Senapathy Gopalakrishnan has donated $1.8 million to CMU to establish a research partnership between CMU and the Center for Brain Research (CBR) at the Indian Institute of Science (IISc) in Bangalore," a statement said today.

  • Strides Arcolab Invests in Oncobiologics Inc

    Strides Arcolab Invests in Oncobiologics Inc

    Strides Arcolab and Oncobiologics Inc said in a statement today that Strides has made a series of strategic investments in privately held New Jersey biopharma firm Oncobiologics Inc.

  • Dr Reddy's Says Drug Price Cap May Not Impact Much: Report

    Dr Reddy's Says Drug Price Cap May Not Impact Much: Report

    A recent government order bringing in some more medicines under control may not have much impact on Hyderabad-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.

  • Sun Pharma Acquires US-Based Pharmalucence

    Sun Pharma Acquires US-Based Pharmalucence

    Sun Pharmaceutical Industries, India's third-largest generic drugmaker by sales, said on Wednesday it had acquired US-based Pharmalucence Inc.

  • Drug Price Cap to Impact MNC Pharma Firms: Prabhudas Lilladher

    Drug Price Cap to Impact MNC Pharma Firms: Prabhudas Lilladher

    According to Prabhudas Lilladher, Glaxo, Sanofi SA and Novartis might get impacted further if the government regulates prices of oncology segment which is growing at a faster rate.

  • Glenmark Gets Final Nod From US Drug Regulator for Skin Cream

    Glenmark Gets Final Nod From US Drug Regulator for Skin Cream

    Glenmark Generics Inc USA, the subsidiary of Glenmark Generics Ltd, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluocinonide cream USP (0.1 per cent), Glenmark Pharmaceuticals said in a statement.

  • India, US Officials Start Talks for Trade Policy Forum Meeting

    India, US Officials Start Talks for Trade Policy Forum Meeting

    Seeking to boost bilateral commerce and investment, India and US trade officials today met to prepare the framework for the ministerial level meeting of the Trade Policy Forum (TPF), a body which has not met since 2010.

  • Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit

    Government Caps Prices of 108 More Medicines; Drugmakers to Take Hit

    The notice by the National Pharmaceutical Pricing Authority (NPPA), published on its website on Friday, coincides with moves by the health ministry to widen the list of essential medicines which will be subject to a price cap, people familiar with the matter told Reuters last month.

Advertisement

Stock Watch

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2014. All rights reserved.